Prompt Description

APPROVED Conceptual schematic illustrating the workflow for identifying and validating potential therapeutic targets of Polyphyllin III in breast cancer. The schematic, designed in a Nature-style format with a clean white background and horizontal left-to-right flow, begins with public breast cancer cohorts and clinical datasets, such as TCGA and METABRIC, represented by database icons and patient silhouettes. A central module depicts the bioinformatic integration of subtype-stratified gene expression analysis, focusing on potential targets including HER2, STAT3, Bcl-2 family proteins, and HIF-1α, across Luminal A, Luminal B, HER2-enriched, and TNBC subtypes. Conceptual association links connect target expression levels with clinical endpoints, specifically overall survival and recurrence-free survival, using abstract survival curve icons. A parallel branch illustrates a comparison between paclitaxel-sensitive and paclitaxel-resistant cohorts, highlighting differential target expression and its association with therapy response. The schematic emphasizes the clinical relevance of these findings.